Australian TGA approves additional indication for Telix's Illuccix® to include patient selection for PSMA-Targeted ...

Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely ...

Biotech innovator NeuroScientific Biopharmaceuticals has received the green light from Australia’s drugs regulator to treat ...

An update from Neuroscientific Biopharmaceuticals Ltd. ( ($AU:NSB) ) is now available. NeuroScientific Biopharmaceuticals has received approval ...

Doctors and nurses working for telehealth companies must ensure patients who use a chatbot or AI to talk about their care ...

Regulators focused on pragmatic safety messaging this week, with aligned statements that paracetamol remains appropriate in ...

But while lecanemab has been shown to slow the progression of disease in some people who receive an early diagnosis, it comes ...

Some international users of Flow Neuroscience's device have labelled the wearable tech as a game-changer in treating ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic ...

In May 2024, New Hyde Park, N.Y.-based Northwell Health and the START Center for Cancer Research — a global network of clinical trial sites — established a partnership to bring an early-stage clinical ...